Table 3.
Low dose | Intermediate dose | High dose | ||||
---|---|---|---|---|---|---|
Acute | Gradual onset | Acute | Gradual onset | Acute | Gradual onset | |
All injuries, n | 8 | 25 | 31 | 93 | 13 | 27 |
Time loss, n (%) | 7 (88) | 9 (36) | 16 (52) | 35 (38) | 5 (38) | 7 (26) |
New injury, n (%) | 7 (88) | 7 (28) | 23 (74) | 35 (38) | 10 (77) | 5 (19) |
Reinjury, n (%) | 1 (12) | 18 (72) | 8 (26) | 58 (62) | 3 (23) | 22 (81) |
Injury location, n (%) | ||||||
Lower limbs | 4 (50) | 19 (76) | 25 (81) | 76 (82) | 11 (85) | 20 (74) |
Hip/groin | 1 (13) | 1 (4) | 3 (10) | 3 (3) | 2 (15) | 3 (11) |
Thigh | 1 (13) | 0 | 8 (26) | 4 (4) | 2 (15) | 0 |
Knee | 1 (13) | 13 (52) | 7 (23) | 53 (57) | 1 (8) | 12 (44) |
Lower leg/Achilles tendon | 0 | 2 (8) | 1 (3) | 8 (9) | 2 (15) | 0 |
Ankle | 1 (13) | 1 (4) | 4 (13) | 1 (1) | 3 (23) | 0 |
Foot/toe | 0 | 2 (8) | 2 (6) | 7 (8) | 1 (8) | 5 (19) |
Trunk | 2 (25) | 0 | 2 (6) | 9 (10) | 1 (8) | 2 (7) |
Upper limbs | 1 (13) | 2 (8) | 3 (10) | 3 (3) | 0 | 3 (11) |
Head and neck | 1 (13) | 0 | 1 (3) | 1 (1) | 1 (8) | 2 (7) |
Other | 0 | 0 | 0 | 1 (1) | 0 | 0 |
Low dose (n = 64): < 1 Knee Control session per week, intermediate dose (n = 185): ≥ 1 to < 2 Knee Control sessions per week, high dose (n = 52): ≥ 2 Knee Control sessions per week